Navigation Links
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
Date:11/22/2009

The Onder Law Firm’s attorneys are offering a free XOLAIR case review to those or families of those who may have experienced heart attack, stroke or other serious health problems after taking XOLAIR.

St. Louis, MO (Vocus) November 22, 2009 -- The Onder Law Firm are among attorneys offering free XOLAIR case review for serious health problems such as heart attack and stroke. The attorneys of the Onder Law Firm include experienced pharmaceutical litigation attorneys. The Onder Law Firm, which handles cases on a national basis, is quickly becoming a leader in large and complex litigation. A partner in the firm was recently appointed as co-lead counsel in the Yaz lawsuit filed in U.S. District Court for the Southern District of Illinois (MDL No. 2100).

The FDA is currently evaluating interim safety findings in an ongoing study of XOLAIR problems. XOLAIR (omalizumab) is an injected drug for asthma related allergies. The interim results of this study, which is being conducted by the drug’s manufacturer, Genentech, Inc., suggests an increased number of cardiovascular (heart attack) and cerebrovascular (stroke) adverse events in a group of patients using Xolair compared to a group of patients not given the drug (control group). The possible association has been identified based on interim results from an ongoing study of Xolair known as Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS). The results this study are not expected until 2012. Although the FDA and the drug manufacturer have not recalled XOLAIR, the FDA wants consumers to be aware of increased risks from taking XOLAIR, specifically heart attack/heart disease and stroke.

The Onder Law Firm, attorneys for XOLAIR cases, have launched a site that contains information regarding XOLAIR side effects and the rights those suffering from them may have. The attorneys of The Onder Law Firm will review will provide free XOLAIR case review to persons having experienced side effects or medical problems after taking the drug. The Onder Law Firm provides experienced legal representation without fee unless it collects for its clients.

About The Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States in pharmaceutical litigation such as Vioxx, Digitek, Ethex and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.onderlaw.com or call 1-877-ONDER-LAW.

# # #

Read the full story at http://www.prweb.com/releases/xolair/lawyers/prweb3244494.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Verdict One Releases Directory of Board Certified Attorneys for Consumers
2. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
3. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
4. Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney
5. Social Security Attorneys Prepare for Increased Baby Boomer SSI Claims
6. Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation
7. Social Security Attorneys Focus on Localized SEO Friendly Content
8. SumoBrain Adds Bulk PDF Downloading : Free Service Saves Money and Time for Attorneys, Inventors and Corporate IP Professionals
9. Cleveland Injury Attorneys Among 'The Best Lawyers in America'
10. Five Lubin & Meyer Lawyers Named Top Medical Malpractice Attorneys: Selected as Super Lawyers 2008
11. Jones Walker Attorneys Named to Positions in Order of British Crown
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: